Patents by Inventor Dirk Iserentant

Dirk Iserentant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10385351
    Abstract: Lactococcus lactis strains with improved preservation characteristics, and improved acid and bile salt tolerance are disclosed. More specifically, a L. lactis strain having a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene, results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. A L. lactis strain, having an internal trehalose concentration of at least 10 mg per gram cells (w/w) is disclosed.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: August 20, 2019
    Assignee: INTREXON ACTOBIOTICS NV
    Inventors: Erik Remaut, Dirk Iserentant
  • Publication number: 20180016587
    Abstract: Lactococcus lactis strains with improved preservation characteristics, and improved acid and bile salt tolerance are disclosed. More specifically, a L. lactis strain having a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene, results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. A L. lactis strain, having an internal trehalose concentration of at least 10 mg per gram cells (w/w) is disclosed.
    Type: Application
    Filed: September 5, 2017
    Publication date: January 18, 2018
    Applicant: INTREXON ACTOBIOTICS NV
    Inventors: Erik REMAUT, Dirk ISERENTANT
  • Patent number: 9790510
    Abstract: Lactococcus lactis strains with improved preservation characteristics, and improved acid and bile salt tolerance are disclosed. More specifically, a L. lactis strain having a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene, results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. A L. lactis strain, having an internal trehalose concentration of at least 10 mg per gram cells (w/w) is disclosed.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: October 17, 2017
    Assignee: INTREXON ACTOBIOTICS NV
    Inventors: Erik Remaut, Dirk Iserentant
  • Publication number: 20160076044
    Abstract: Lactococcus lactis strains with improved preservation characteristics, and improved acid and bile salt tolerance are disclosed. More specifically, a L. lactis strain having a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene, results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. A L. lactis strain, having an internal trehalose concentration of at least 10 mg per gram cells (w/w) is disclosed.
    Type: Application
    Filed: November 6, 2015
    Publication date: March 17, 2016
    Inventors: Erik Remaut, Dirk Iserentant
  • Patent number: 9200249
    Abstract: Lactococcus lactis strains with improved preservation characteristics, and improved acid and bile salt tolerance are disclosed. More specifically, a L. lactis strain having a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene, results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. A L. lactis strain, having an internal trehalose concentration of at least 10 mg per gram cells (w/w) is disclosed.
    Type: Grant
    Filed: August 18, 2005
    Date of Patent: December 1, 2015
    Assignee: ACTOGENIX N.V.
    Inventors: Erik Remaut, Dirk Iserentant
  • Publication number: 20090170949
    Abstract: The present invention relates to a method to treat obesity and/or a method to lose or control body weight. More specifically, the invention relates to the use of a compound inhibiting the sweet taste perception, preferably by inactivating the T1R3 receptor, for the preparation of a medicament to treat or prevent obesity and/or to treat or prevent diabetes and/or to lose or control body weight.
    Type: Application
    Filed: January 23, 2007
    Publication date: July 2, 2009
    Inventors: Soraya Shirazi-Beechey, Dirk Iserentant
  • Publication number: 20080254014
    Abstract: An administration strategy is disclosed for the delivery at the intestinal mucosa of anti-inflammatory compounds, preferably acid-sensitive anti-inflammatory agents, such as IL10 and/or a soluble TNF receptor and/or trefoil factor via the oral route. In particular, inoculation with a suspension of live recombinant yeast cells, preferably Saccharomyces cells, which have been engineered to produce the respective proteins, is disclosed.
    Type: Application
    Filed: October 2, 2006
    Publication date: October 16, 2008
    Applicant: ActoGeniX N V
    Inventors: Pieter Rottiers, Klaas Vandenbroucke, Dirk Iserentant
  • Publication number: 20070258965
    Abstract: Lactococcus lactis strains with improved preservation characteristics, and improved acid and bile salt tolerance are disclosed. More specifically, a L. lactis strain having a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene, results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. A L. lactis strain, having an internal trehalose concentration of at least 10 mg per gram cells (w/w) is disclosed.
    Type: Application
    Filed: August 18, 2005
    Publication date: November 8, 2007
    Inventors: Erik Remaut, Dirk Iserentant
  • Patent number: 7241462
    Abstract: Process for the preparation of malted cereals, wherein the steeping step includes one or more wetting stages at a temperature between 5 and 30° C. preferably between 10 and 20° C., until the material has a moisture content between 20 and 60% by weight, preferably between 38 and 47%, wherein after a germination period between 2 and 7 days, preferably between 3 to 6 days at a temperature between 10 and 30° C., preferably between 14 and 18° C., the steeped and germinated cereals are preferably kilned by increasing the temperature to values between 40 and 150° C. until the material has a moisture content between 2 and 15% by weight, and wherein one or more microbial cultures selected from the group consisting of one or more bacteria and/or one of more activated spores are added in one or more times during the process.
    Type: Grant
    Filed: July 23, 1997
    Date of Patent: July 10, 2007
    Inventors: Theo Coppens, Jan Delcour, Dirk Iserentant
  • Publication number: 20010001673
    Abstract: Proces for the preparation of malted cereals, wherein the steeping step includes one or more wetting stages at a temperature and 30° C. preferably between 10 and 20° C., until the material has a moisture content between 20 and 60% by weight, preferably between 38 and 47%, wherein aftr a germination period between 2 and 7 days, preferably between 3 to 6 days at a temperature between 10 and 30° C., preferably between 14 and 18° C., the steeped and germinated cereals are preferably kilned by increasing the temperature to values between 40 and 150° C. until the material has a moisture content between 2 and 15% by weight, and wherein one or more microbial cultures selected from the group consisting of one or more bacteria and/or one of more activated spores are added in one or more times during the process.
    Type: Application
    Filed: July 23, 1997
    Publication date: May 24, 2001
    Applicant: THEO COPPENS
    Inventors: THEO COPPENS, JAN DELCOUR, DIRK ISERENTANT